Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Pill after intracerebral haemorrhage
ACTRN12616000327482Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of telmisartan, amlodipine and indapamide in intracerebral hemorrhage (ICH) and hypertension (HTN) (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: Time to first recurrent stroke. Started Sep 2017; status: completed.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
intracerebral hemorrhage (ICH)hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12616000327482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000327482.